Dublin, Aug. 15, 2019 (GLOBE NEWSWIRE) -- The "Blood Screening - Market Analysis, Trends, and Forecasts" report has been added to ResearchAndMarkets.com's offering.

Blood Screening market worldwide is projected to grow by US$1.7 Billion, guided by a compounded growth of 8.8%.

Staying on top of trends is essential for decision makers to leverage this emerging opportunity. The report addresses this very need and provides the latest scoop on all major market segments.

Nucleic Acid Test (NAT), one of the segments analyzed and sized in this study, displays the potential to grow at over 8.5%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$1.7 Billion by the year 2025, Nucleic Acid Test (NAT) will bring in healthy gains adding significant momentum to global growth.

While global megatrends sweeping through the market influence the primary direction of growth, regional markets are swayed by more granular locally unique business drivers. Representing the developed world, the United States will maintain a 13.7% growth momentum.

Within Europe, which continues to remain an important element in the world economy, Germany will add over US$65.4 Million to the region's size and clout in the next 5 to 6 years. Over US$126.5 Million worth of projected demand in the region will come from other emerging Eastern European markets.

In Japan, Nucleic Acid Test (NAT) will reach a market size of US$96.5 Million by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 12.7% over the next couple of years and add approximately US$454.8 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders.

Competitors identified in this market include:

• Abbott Laboratories (USA)
• Beckman Coulter, Inc. (USA)
• Becton, Dickinson & Company (USA)
• bioMerieux SA (France)
• Bio-Rad Laboratories, Inc. (USA)
• F. Hoffmann-La Roche AG (Switzerland)
• Grifols International SA (Spain)
• Ortho Clinical Diagnostics, Inc. (USA)
• Siemens Healthineers (Germany)
• Thermo Fisher Scientific, Inc. (USA)

Key Topics Covered

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

• Global Competitor Market Shares
• Blood Screening Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
• Global Competitor Market Shares by Segment
• Nucleic Acid Test (NAT) (Technology) Global Competitor Market Share Positioning for 2019 & 2025
• Enzyme-Linked Immunosorbent Assay (ELISA) (Technology) Market Share Breakdown of Key Players: 2019 & 2025
• Rapid Tests (Technology) Competitor Revenue Share (in %): 2019 & 2025
• Western Blot Assay (Technology) Market Share Shift by Company: 2019 & 2025
• Next-Generation Sequencing (NGS) (Technology) Global Competitor Market Share Positioning for 2019 & 2025
• Reagents & Kits (Product & Service) Market Share Breakdown of Key Players: 2019 & 2025
• Instruments (Product & Service) Competitor Revenue Share (in %): 2019 & 2025
• Software & Services (Product & Service) Market Share Shift by Company: 2019 & 2025

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES

• Market Facts & Figures
• US Blood Screening Market Share (in %) by Company: 2019 & 2025
• Nucleic Acid Test (NAT) (Technology) Market Share Analysis (in %) of Leading Players in the US for 2019 & 2025
• Enzyme-Linked Immunosorbent Assay (ELISA) (Technology) Competitor Revenue Share (in %) in the US: 2019 & 2025
• Rapid Tests (Technology) Market Share Breakdown (in %) of Major Players in the US: 2019 & 2025
• Western Blot Assay (Technology) Market in the US: Percentage Breakdown of Revenues by Company for 2019 & 2025
• Next-Generation Sequencing (NGS) (Technology) Competitor Market Share Breakdown (in %) in the US for 2019 & 2025
• Reagents & Kits (Product & Service) Market: Revenue Share Breakdown (in %) of Key Players in the US: 2019 & 2025
• Instruments (Product & Service) Market Share Analysis (in %) of Leading Players in the US for 2019 & 2025
• Software & Services (Product & Service) Competitor Revenue Share (in %) in the US: 2019 & 2025

CANADA

JAPAN

CHINA

EUROPE

• Market Facts & Figures
• European Blood Screening Market: Competitor Market Share Scenario (in %) for 2019 & 2025
• Nucleic Acid Test (NAT) (Technology) Market Share (in %) by Company in Europe: 2019 & 2025
• Enzyme-Linked Immunosorbent Assay (ELISA) (Technology) Market Share (in %) of Major Players in Europe: 2019 & 2025
• Rapid Tests (Technology) Competitor Market Share Analysis (in %) in Europe: 2019 & 2025
• Western Blot Assay (Technology) Market in Europe: Competitor Revenue Share Shift (in %) for 2019 & 2025
• Next-Generation Sequencing (NGS) (Technology) Competitor Market Share (in %) Positioning in Europe for 2019 & 2025
• Reagents & Kits (Product & Service) Key Player Market Share Breakdown (in %) in Europe: 2019 & 2025
• Instruments (Product & Service) Market Share (in %) by Company in Europe: 2019 & 2025
• Software & Services (Product & Service) Market Share (in %) of Major Players in Europe: 2019 & 2025

FRANCE

GERMANY

ITALY

UNITED KINGDOM

SPAIN

RUSSIA

REST OF EUROPE

ASIA-PACIFIC

AUSTRALIA

INDIA

SOUTH KOREA

REST OF ASIA-PACIFIC

LATIN AMERICA

ARGENTINA

BRAZIL

MEXICO

REST OF LATIN AMERICA

MIDDLE EAST

IRAN

ISRAEL

SAUDI ARABIA

UNITED ARAB EMIRATES

REST OF MIDDLE EAST

AFRICA

IV. COMPETITION

V. CURATED RESEARCH

For more information about this report visit https://www.researchandmarkets.com/r/ncuv5w

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Press Manager
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900